Insider Trading activities at Perspective Therapeutics, Inc. (CATX)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Perspective Therapeutics, Inc. (CATX) since 2005 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Perspective Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 728387.

Total stock buying since 2005: $59,936,685.
Total stock sales since 2005: $359,072.
Total stock option exercises since 2005: $699,141.


24 insiders reported insider trading activities at Perspective Therapeutics, Inc. (CATX):
Insider trading activities of Henson Heidi
Insider trading activities of Lavoy Thomas C
Insider trading activities of Hoffmann Alan
Insider trading activities of Austin Mark John
Insider trading activities of Girard Roger
Insider trading activities of Williamson Robert F Iii
Insider trading activities of Boatwright Stephen
Insider trading activities of Streeter Jennifer
Insider trading activities of Cavanagh William
Insider trading activities of Swindler Fredric
Insider trading activities of Spoor Johan M.
Insider trading activities of Smith Albert Louis
Insider trading activities of Lantheus Holdings, Inc.
Insider trading activities of Babcock Dwight William
Insider trading activities of Puhlmann Markus
Insider trading activities of Mccormick Michael W
Insider trading activities of Hunt Jonathan Robert
Insider trading activities of Cline Krista
Insider trading activities of Krachon Michael
Insider trading activities of Swanberg David
Insider trading activities of Vitale Philip J
Insider trading activities of Ragle Brien
Insider trading activities of Kauffman Robert R
Insider trading activities of Woods Lori A

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Perspective Therapeutics, Inc. (CATX).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 50,151 $109,408 0 $0 0 $0
2024 61,301,323 $58,357,890 0 $0 30,000 $10,800
2023 747,768 $229,536 0 $0 187,500 $114,374
2022 718,204 $238,752 0 $0 22,500 $7,425
2021 0 $0 0 $0 337,500 $167,400
2020 297,608 $144,960 0 $0 262,500 $130,725
2019 210,000 $82,650 0 $0 21,900 $5,694
2018 261,735 $107,499 0 $0 0 $0
2017 134,265 $68,055 0 $0 82,810 $50,100
2016 122,000 $96,425 0 $0 0 $0
2015 65,029 $96,573 13,340 $20,410 13,340 $13,073
2014 0 $0 80,571 $188,166 80,571 $40,972
2013 25,000 $13,250 0 $0 0 $0
2012 134,600 $59,923 11,334 $11,220 11,334 $2,946
2011 116,912 $98,371 22,666 $22,701 72,666 $55,392
2009 47,654 $9,530 0 $0 0 $0
2008 142,854 $49,633 0 $0 0 $0
2007 27,300 $63,768 0 $0 60,000 $71,400
2006 10,000 $28,500 24,236 $116,575 24,236 $28,840
2005 23,923 $81,962 0 $0 0 $0

Table 2. Monthly summary of insider trading at Perspective Therapeutics, Inc. (CATX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-03 50,151 $109,408 0 $0 0 $0
2024-12 33,975 $130,139 0 $0 0 $0
2024-11 45,595 $171,412 0 $0 0 $0
2024-06 140,633 $234,834 0 $0 0 $0
2024-05 55,000 $75,900 0 $0 0 $0
2024-04 0 $0 0 $0 30,000 $10,800
2024-03 60,431,039 $57,409,487 0 $0 0 $0
2024-01 595,081 $336,118 0 $0 0 $0
2023-12 747,768 $229,536 0 $0 0 $0
2023-04 0 $0 0 $0 187,500 $114,374
2022-12 85,404 $32,506 0 $0 0 $0
2022-11 500,000 $167,500 0 $0 0 $0
2022-08 0 $0 0 $0 22,500 $7,425
2022-06 132,800 $38,746 0 $0 0 $0
2021-11 0 $0 0 $0 125,000 $55,625
2021-03 0 $0 0 $0 212,500 $111,775
2020-11 68,000 $25,568 0 $0 0 $0
2020-10 229,608 $119,392 0 $0 0 $0
2020-02 0 $0 0 $0 262,500 $130,725
2019-11 210,000 $82,650 0 $0 0 $0
2019-05 0 $0 0 $0 21,900 $5,694
2018-11 201,735 $81,349 0 $0 0 $0
2018-03 60,000 $26,150 0 $0 0 $0
2017-11 94,265 $44,295 0 $0 82,810 $50,100

Table 3. Detailed insider trading at Perspective Therapeutics, Inc. (CATX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-03-31 Woods Lori A Buy 23,475 2.13 50,001
2025-03-28 Spoor Johan M. (Chief Executive Officer) Buy 26,676 2.23 59,407
2024-12-04 Spoor Johan M. (CEO) Buy 8,000 3.77 30,136
2024-12-04 Henson Heidi Buy 25,975 3.85 100,003
2024-11-25 Spoor Johan M. (CEO) Buy 26,500 3.79 100,567
2024-11-25 Williamson Robert F Iii Buy 6,266 3.65 22,839
2024-11-25 Hunt Jonathan Robert (Chief Financial Officer) Buy 12,829 3.74 48,006
2024-06-17 Hunt Jonathan Robert (Chief Financial Officer) Buy 1,800 9.81 17,667
2024-06-14 Woods Lori A Buy 4,587 10.85 49,768
2024-06-13 Spoor Johan M. (CEO) Buy 100,000 1.17 117,400
2024-06-03 Woods Lori A Buy 34,246 1.46 49,999
2024-05-31 Williamson Robert F Iii Buy 55,000 1.38 75,900
2024-04-23 Austin Mark John (VP Finance/Prin Fin&Acct Offic) Option Ex 30,000 .36 10,800
2024-03-06 Lantheus Holdings, Inc. Buy 60,431,039 .95 57,409,487
2024-01-30 Williamson Robert F Iii (Director) Buy 127,206 .71 90,316
2024-01-29 Williamson Robert F Iii (Director) Buy 25,266 .64 16,170
2024-01-26 Williamson Robert F Iii (Director) Buy 110,613 .58 64,155
2024-01-25 Williamson Robert F Iii (Director) Buy 22,134 .49 10,845
2024-01-24 Puhlmann Markus (Chief Medical Officer) Buy 280,000 .50 140,000
2024-01-24 Williamson Robert F Iii (Director) Buy 29,862 .49 14,632
2023-12-21 Williamson Robert F Iii (Director) Buy 3,663 .33 1,201
2023-12-19 Puhlmann Markus (Chief Medical Officer) Buy 400,000 .34 137,200
2023-12-19 Williamson Robert F Iii (Director) Buy 13,680 .32 4,377
2023-12-18 Puhlmann Markus (Chief Medical Officer) Buy 60,419 .26 15,467
2023-12-18 Williamson Robert F Iii (Director) Buy 10,000 .26 2,600
2023-12-18 Hunt Jonathan Robert (Chief Financial Officer) Buy 125,000 .26 32,375
2023-12-15 Puhlmann Markus (Chief Medical Officer) Buy 135,006 .27 36,316
2023-04-17 Woods Lori A (Director) Option Ex 23,566 .61 14,375
2023-04-13 Woods Lori A (Director) Option Ex 163,934 .61 99,999
2022-12-05 Hunt Jonathan Robert (Chief Financial Officer) Buy 32,200 .38 12,236
2022-12-01 Hunt Jonathan Robert (Chief Financial Officer) Buy 53,204 .38 20,270
2022-11-15 Woods Lori A (CEO) Buy 300,000 .34 100,500
2022-08-05 Streeter Jennifer (COO & VP of HR) Option Ex 22,500 .33 7,425
2022-06-09 Austin Mark John (VP Finance/Prin Fin&Acct Offic) Buy 13,800 .29 3,960
2022-06-08 Austin Mark John (VP Finance/Prin Fin&Acct Offic) Buy 5,000 .28 1,424
2022-06-08 Hunt Jonathan Robert (Chief Financial Officer) Buy 25,675 .29 7,445
2022-06-07 Woods Lori A (CEO) Buy 75,000 .30 22,200
2022-06-07 Hunt Jonathan Robert (Chief Financial Officer) Buy 13,325 .28 3,717
2021-11-23 Woods Lori A (CEO) Option Ex 125,000 .45 55,625
2021-03-12 Woods Lori A (CEO) Option Ex 212,500 .53 111,775
2020-11-30 Woods Lori A (CEO) Buy 68,000 .38 25,568
2020-10-22 Austin Mark John (Controller/Prin Fin&Acct Offic) Buy 19,230 .52 9,999
2020-10-22 Krachon Michael (EVP of Sales & Marketing) Buy 28,844 .52 14,998
2020-10-22 Hoffmann Alan (Director) Buy 19,230 .52 9,999
2020-10-22 Vitale Philip J (Director) Buy 20,000 .52 10,400
2020-10-22 Cavanagh William (Chief R&D Officer) Buy 7,692 .52 3,999
2020-10-22 Woods Lori A (CEO) Buy 48,076 .52 24,999
2020-10-22 Hunt Jonathan Robert (Chief Financial Officer) Buy 67,306 .52 34,999
2020-10-22 Mccormick Michael W (Director) Buy 19,230 .52 9,999
2020-02-03 Woods Lori A (CEO) Option Ex 262,500 .50 130,725
2019-11-20 Krachon Michael (VP of Sales & Marketing) Buy 50,000 .39 19,500
2019-11-15 Cavanagh William (Chief R&D Officer) Buy 10,000 .39 3,900
2019-11-15 Woods Lori A (CEO) Buy 25,000 .39 9,750
2019-11-14 Woods Lori A (CEO) Buy 125,000 .40 49,500
2019-05-30 Cline Krista (Dir. of Operations, Secretary) Option Ex 21,900 .26 5,694
2018-11-20 Hoffmann Alan (Director) Buy 25,000 .40 10,000
2018-11-16 Austin Mark John (Controller/Prin Fin&Acct Offic) Buy 4,283 .40 1,704
2018-11-16 Cavanagh William (COO, CSO) Buy 10,000 .40 4,000
2018-11-15 Woods Lori A (Interim CEO) Buy 5,000 .40 1,990
2018-11-14 Woods Lori A (Interim CEO) Buy 125,000 .40 49,750
2018-11-13 Austin Mark John (Controller/Prin Fin&Acct Offic) Buy 2,452 .41 1,005
2018-11-13 Vitale Philip J (Director) Buy 30,000 .43 12,900
2018-03-14 Vitale Philip J (Director) Buy 10,000 .44 4,400
2018-03-01 Lavoy Thomas C (CEO and Chairman of the Board) Buy 50,000 .43 21,750
2017-11-24 Austin Mark John (Controller/Prin Fin&Acct Offic) Buy 2,040 .49 1,005
2017-11-22 Austin Mark John (Controller/Prin Fin&Acct Offic) Buy 1,825 .49 894
2017-11-21 Austin Mark John (Controller/Prin Fin&Acct Offic) Buy 5,400 .48 2,581
2017-11-20 Krachon Michael (VP of Sales & Marketing) Buy 55,000 .48 26,675
2017-11-20 Lavoy Thomas C (CEO and Chairman of the Board) Option Ex 82,810 .60 50,100
2017-11-16 Vitale Philip J (Director) Buy 30,000 .44 13,140
2017-03-10 Lavoy Thomas C (CEO) Buy 20,000 .53 10,600
2017-01-04 Vitale Philip J (Director) Buy 20,000 .66 13,160
2016-12-08 Hoffmann Alan (Director) Buy 20,000 .57 11,399
2016-11-17 Lavoy Thomas C (CEO) Buy 20,000 .60 12,000
2016-03-17 Lavoy Thomas C (CEO) Buy 13,294 .90 11,964
2016-03-11 Vitale Philip J (Director) Buy 10,000 .93 9,320
2016-03-11 Lavoy Thomas C (CEO) Buy 36,706 .89 32,668
2016-03-08 Mccormick Michael W (Director) Buy 22,000 .87 19,074
2015-11-12 Babcock Dwight William (CEO) Buy 25,000 1.26 31,550
2015-06-09 Babcock Dwight William (CEO) Buy 10,000 1.53 15,280
2015-04-02 Cavanagh William (Vice President) Sale 13,340 1.53 20,410
2015-04-02 Cavanagh William (Vice President) Option Ex 13,340 .98 13,073
2015-03-06 Lavoy Thomas C (Director) Buy 10,000 1.66 16,600
2015-03-05 Vitale Philip J (Director) Buy 10,000 1.80 18,000
2015-03-03 Babcock Dwight William (CEO) Buy 7,500 1.51 11,325
2015-03-02 Babcock Dwight William (CEO) Buy 2,529 1.51 3,818
2014-06-10 Swindler Fredric (Vice President) Sale 25,000 2.54 63,549
2014-06-10 Swindler Fredric (Vice President) Option Ex 25,000 .26 6,500
2014-06-03 Swindler Fredric (Vice President) Sale 25,000 2.27 56,750
2014-06-03 Swindler Fredric (Vice President) Option Ex 25,000 .26 6,500
2014-05-27 Cavanagh William (Vice President) Sale 30,571 2.22 67,867
2014-05-27 Cavanagh William (Vice President) Option Ex 30,571 .92 27,972
2013-11-01 Babcock Dwight William (CEO) Buy 25,000 .53 13,250
2012-11-28 Lavoy Thomas C (Director) Buy 18,100 .49 8,869
2012-11-21 Babcock Dwight William (CEO) Buy 10,100 .40 4,040
2012-11-19 Babcock Dwight William (CEO) Buy 4,800 .37 1,776
2012-11-19 Kauffman Robert R (Director) Buy 25,000 .38 9,500
2012-11-16 Babcock Dwight William (CEO) Buy 35,100 .41 14,285
2012-07-06 Ragle Brien (Controller) Sale 11,334 .99 11,220
2012-07-06 Ragle Brien (Controller) Option Ex 11,334 .26 2,946
2012-03-22 Babcock Dwight William (CEO) Buy 12,000 .52 6,192
2012-03-20 Babcock Dwight William (CEO) Buy 8,000 .50 4,000
2012-02-21 Babcock Dwight William (CEO) Buy 1,000 .51 510
2012-02-17 Babcock Dwight William (CEO) Buy 10,000 .54 5,400
2011-12-21 Babcock Dwight William (CEO) Buy 20,052 .68 13,634
2011-12-20 Babcock Dwight William (CEO) Buy 19,948 .68 13,564
2011-11-21 Babcock Dwight William (CEO) Buy 3,200 .85 2,710
2011-11-18 Babcock Dwight William (CEO) Buy 1,000 .83 830
2011-11-17 Babcock Dwight William (CEO) Buy 5,000 .77 3,850
2011-06-24 Kauffman Robert R (Director) Option Ex 25,000 .99 24,750
2011-06-21 Lavoy Thomas C (Director) Option Ex 25,000 .99 24,750
2011-06-01 Ragle Brien (Controller) Sale 11,333 1.00 11,333
2011-06-01 Ragle Brien (Controller) Option Ex 11,333 .26 2,946
2011-05-26 Ragle Brien (Controller) Sale 4,227 1.00 4,227
2011-05-26 Ragle Brien (Controller) Option Ex 11,333 .26 2,946
2011-05-25 Ragle Brien (Controller) Sale 7,106 1.00 7,141
2011-03-15 Babcock Dwight William (CEO) Buy 5,000 1.05 5,250
2011-03-08 Babcock Dwight William (CEO) Buy 4,600 1.16 5,340
2011-02-28 Babcock Dwight William (CEO) Buy 16,900 1.30 21,970
2011-02-23 Babcock Dwight William (CEO) Buy 6,612 1.29 8,529
2011-02-17 Babcock Dwight William (CEO) Buy 10,000 .54 5,400
2009-02-27 Babcock Dwight William (CEO) Buy 600 .20 120
2009-02-26 Babcock Dwight William (CEO) Buy 47,054 .20 9,410
2008-12-18 Babcock Dwight William (Interim CEO) Buy 8,900 .23 2,047
2008-12-12 Babcock Dwight William (Interim CEO) Buy 7,300 .22 1,606
2008-12-11 Babcock Dwight William (Interim CEO) Buy 800 .21 168
2008-12-10 Babcock Dwight William (Interim CEO) Buy 200 .21 42
2008-11-26 Smith Albert Louis (Director) Buy 75,954 .26 19,444
2008-11-26 Lavoy Thomas C (Director) Buy 32,000 .29 9,408
2008-05-19 Woods Lori A (Acting COO) Buy 5,000 .90 4,495
2008-05-19 Smith Albert Louis (Director) Buy 4,200 .89 3,738
2008-05-19 Babcock Dwight William (Interim CEO) Buy 5,000 .89 4,450
2008-02-15 Swanberg David (EVP Operations & Secretary) Buy 3,500 1.21 4,235
2007-11-14 Swanberg David (EVP Operations & Secretary) Buy 600 2.21 1,326
2007-11-13 Swanberg David (EVP Operations & Secretary) Buy 4,500 2.23 10,057
2007-11-12 Smith Albert Louis (Director) Buy 9,000 2.43 21,870
2007-11-12 Swanberg David (EVP Operations & Secretary) Buy 10,700 2.29 24,503
2007-11-12 Girard Roger (CEO & President) Buy 2,500 2.40 6,012
2007-03-01 Boatwright Stephen (Director) Option Ex 60,000 1.19 71,400
2006-12-06 Boatwright Stephen (Director) Sale 24,236 4.81 116,575
2006-11-27 Boatwright Stephen (Director) Option Ex 24,236 1.19 28,840
2006-09-20 Babcock Dwight William (Director) Buy 10,000 2.85 28,500
2005-11-08 Swanberg David (Secretary) Buy 3,000 4.00 12,000
2005-10-28 Swanberg David (Secretary) Buy 12,500 4.00 50,000
2005-08-11 Lavoy Thomas C (Director) Buy 8,423 2.37 19,962

Insider trading activities including stock purchases, stock sales, and option exercises of CATX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Perspective Therapeutics, Inc. (symbol CATX, CIK number 728387) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.